Evidence of adherence to allergen-specific immunotherapy

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 6, 2009, Pages 544-548

  Senna, Gianenrico ^a   Ridolo, Erminia ^b   Calderon, Moises ^c   Lombardi, Carlo ^d   Canonica, Giorgio W ^e   Passalacqua, Giovanni ^e  

^a Animal Hospital of Verona   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d S Orsola FBF Hospital   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Adherence; Allergen specific immunotherapy; Allergic asthma; Allergic rhinitis; Compliance

Indexed keywords

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC ASTHMA; ALLERGIC RHINITIS; COST; HUMAN; IMMUNOTHERAPY; LONG TERM CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION;

ALLERGENS; ANIMALS; ASTHMA; COST OF ILLNESS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION ROUTES; EDUCATION, MEDICAL, CONTINUING; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC;

EID: 70350761754     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328332b8df     Document Type: Review

References (42)

1. Passalacqua G, Durham SR. ARIA update: allergen immunotherapy. JACI 2007; 119:881-891.
2. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985-1997.
3. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003:CD001186.
4. Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007:CD001936.
5. Canonica GW, Passalacqua G. Noninjection routes of immunotherapy. J Allergy Clin Immunol 2003; 111:437-448.
6. Wilson DR, Torres L, Durham SR. Sublingual immunotherapy for allergic rhinitis. Allergy 2005; 60:3-8.
7. PenagosM,Compalati E, Tarantini F, et al. Efficacy of sublingualimmunotherapy in the treatment of allergic rhinitis in children: meta analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2006; 97:141-148.
8. Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008; 133:599-609.
9. Compalati E, Penagos M, Tarantini F, et al. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol 2009; 102:22-28.
10. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinits and its impact on asthma. Allergy 2008; 63 (Suppl 6):S1-S30.
11. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass pollen immunotherapy. N Engl J Med 1999; 7:468-475.
12. Berto P, Passalacqua G, Crimi N, et al. Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI study). Ann Allergy Asthma Immunol 2006; 97:615-621.
13. Ostergberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-497.
14. Baiardini I, Braido F, Bonini M, et al. Why do doctors and patients not follow guidelines. Curr Opin Allergy Clin Immunol 2009; 9:228-233.
15. Wahl C, Gregoire JP, Teo K, et al. Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes. Healthc Q 2005; 8:65-70.
16. Boudes P. Drug compliance in therapeutic trials: a review. Control Clin Trials 1998; 19:257-268.
17. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993; 91:734-737.
18. Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993; 70:480-482.
19. Tinkelman D, Smith F, Cole WD 3rd, Slik HJ. Compliance with an allergen immunotherapy regimen. Ann Allergy Asthma Immunol 1995; 74:241-246.
20. Ruiz FJ, Jimenez A, Cocoletzi J, Duran E. Compliance with and abandonment of immunotherapy. Rev Alerg Mex 1997; 44:42-44.
21. Donahue JG, Greineder DK, Connor-Lacke L, et al. Utilization and cost of immunotherapy for allergic asthma and rhinitis. Ann Allergy Asthma Immunol 1999; 82:339-347.
22. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol 1999; 82:281-286.
23. More DR, Hagan LL. Factors affecting compliance with allergy immunotherapy at a military medical center. Ann Allergy Asthma Immunol 2002; 88:391-394.
24. Pajno GB, Vita D, Caminiti L, et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 2005; 116:1380-1381.
25. Marogna M, Spadolini I, Massolo A, et al. Randomized controlled open study of SLIT for respiratory allergy in real life: clinical efficacy and more. Allergy 2004; 59:1205-1210.
26. Lombardi C, Gani F, Landi M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004; 113:1219-1220.
27. Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy regimen in real life (EASY project: evaluation of a novel SLIT formulation during a year). J Allergy Clin Immunol 2006; 117:946-948.
28. Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007; 18:58-62.
29. Roder E, Berger MY, de Groot H, ven Wijk RG. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial. Clin Exp Allergy 2008; 38:1669-1767.
30. Jansen A, Andersen KF, Bruning H. Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (Grazax) in a randomized open-label, controlled study: an a priori subgroup analysis. Clin Ther 2009; 31:321-327.
31. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117:802-809.
32. Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64:179-186.
33. Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5 grass pollen sublingual immunotherapy in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123:160.e3-166.e3.
34. Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-173.
35. Andri L, Senna GE, Dama AR. Clinical efficacy and safety of local nasal immunotherapy. Allergy 1997; 52 (Suppl 33):36-39.
36. Tsai JJ, Liao EC, Tsai FH, et al. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus. J Asthma 2009; 46:165-170.
37. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutical vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558-562. (Pubitemid 28487930)
38. Canonica GW, Baena Cagnani C, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy: a statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62:317-324.
39. Bousquet PJ, Demoly P, Passalacqua G, et al. Immunotherapy: clinical trials -optimal trial and clinical outcomes. Curr Opin Allergy Clin Immunol 2007; 7:561-566.
40. Berto P, Frati F, Incorvaia C. Economic studies of immunotherapy: a review. Curr Opin Allergy Clin Immunol 2008; 8:585-589.
41. Passalacqua G, Frati F, Puccinelli P, et al. Compliance with sublingual immunotherapy: the allergists' viewpoint. Allergy 2009 [Epub ahead of print].
42. Sade K, Berkun Y, Dolev Z, et al. Knowledge and expectations of patients receiving aeroallergen immunotherapy. Ann Allergy Asthma Immunol 2003; 91:444-448.